|
1
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alitalo K, Tammela T and Petrova TV:
Lymphangiogenesis in development and human disease. Nature.
438:946–953. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Läubli H and Borsig L: Selectins promote
tumor metastasis. Semin Cancer Biol. 20:169–177. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Arabzadeh A, Chan C, Nouvion AL, Breton V,
Benlolo S, DeMarte L, Turbide C, Brodt P, Ferri L and Beauchemin N:
Host-related carcinoembryonic antigen cell adhesion molecule 1
promotes metastasis of colorectal cancer. Oncogene. 32:849–860.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Desgrosellier JS and Cheresh DA: Integrins
in cancer: Biological implications and therapeutic opportunities.
Nat Rev Cancer. 10:9–22. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
van Gisbergen KP, Aarnoudse CA, Meijer GA,
Geijtenbeek TB and van Kooyk Y: Dendritic cells recognize
tumor-specific glycosylation of carcinoembryonic antigen on
colorectal cancer cells through dendritic cell-specific
intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res.
65:5935–5944. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang Y, Zhang C, Chen K, Chen Z, Sun Z,
Zhang Z, Ding D, Ren S and Zuo Y: The clinical significance of
DC-SIGN and DC-SIGNR, which are novel markers expressed in human
colon cancer. PLoS One. 9:e1147482014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zuo Y, Ren S, Wang M, Liu B, Yang J, Kuai
X, Lin C, Zhao D, Tang L and He F: Novel roles of liver sinusoidal
endothelial cell lectin in colon carcinoma cell adhesion, migration
and in vivo metastasis to the liver. Gut. 62:1169–1178. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kannagi R, Izawa M, Koike T, Miyazaki K
and Kimura N: Carbohydrate-mediated cell adhesion in cancer
metastasis and angiogenesis. Cancer Sci. 95:377–384. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feinberg H, Mitchell DA, Drickamer K and
Weis WI: Structural basis for selective recognition of
oligosaccharides by DC-SIGN and DC-SIGNR. Science. 294:2163–2166.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kansas GS: Selectins and their ligands:
Current concepts and controversies. Blood. 88:3259–3287.
1996.PubMed/NCBI
|
|
14
|
Martinez-Pomares L: The mannose receptor.
J Leukoc Biol. 92:1177–1186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mitchell DA, Fadden AJ and Drickamer K: A
novel mechanism of carbohydrate recognition by the C-type lectins
DC-SIGN and DC-SIGNR. Subunit organization and binding to
multivalent ligands. J Biol Chem. 276:28939–28945. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zarbock A, Ley K, McEver RP and Hidalgo A:
Leukocyte ligands for endothelial selectins: Specialized
glycoconjugates that mediate rolling and signaling under flow.
Blood. 118:6743–6751. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pals ST, de Gorter DJ and Spaargaren M:
Lymphoma dissemination: The other face of lymphocyte homing. Blood.
110:3102–3111. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qian F, Hanahan D and Weissman IL:
L-selectin can facilitate metastasis to lymph nodes in a transgenic
mouse model of carcinogenesis. Proc Natl Acad Sci USA.
98:3976–3981. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sperandio M: Selectins and
glycosyltransferases in leukocyte rolling in vivo. FEBS J.
273:4377–4389. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Girard JP, Moussion C and Förster R: HEV,
lymphatics and homeostatic immune cell trafficking in lymph nodes.
Nat Rev Immunol. 12:762–773. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Irjala H, Johansson EL, Grenman R, Alanen
K, Salmi M and Jalkanen S: Mannose receptor is a novel ligand for
L-selectin and mediates lymphocyte binding to lymphatic
endothelium. J Exp Med. 194:1033–1042. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zuo Y, Wei W, Liu C, Zhao L, Wang L and
Zhang J: Silencing L-selectin expression by siRNA attenuated
metastasis of murine lymphoid neoplasm cell P388D1 to peripheral
lymph nodes. Leukemia. 21:180–183. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wei W, Zuo Y, Hu Y, Wang L, Jia L and
Zhang J: Heparin inhibits P388D1 cells adherence and metastasis to
peripheral lymph nodes in vitro and in vivo. Lymphology. 42:10–18.
2009.PubMed/NCBI
|
|
24
|
Aviram R, Raz N, Kukulansky T and
Hollander N: Expression of L-selectin and efficient binding to high
endothelial venules do not modulate the dissemination potential of
murine B-cell lymphoma. Cancer Immunol Immunother. 50:61–68. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei J, Cui L, Liu F, Fan Y, Lang R, Gu F,
Guo X, Tang P and Fu L: E-selectin and Sialyl Lewis X expression is
associated with lymph node metastasis of invasive micropapillary
carcinoma of the breast. Int J Surg Pathol. 18:193–200. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gay LJ and Felding-Habermann B:
Contribution of platelets to tumour metastasis. Nat Rev Cancer.
11:123–134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gout S, Tremblay PL and Huot J: Selectins
and selectin ligands in extravasation of cancer cells and organs
electivity of metastasis. Clin Exp Metastasis. 25:335–344. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tomlinson J, Wang JL, Barsky SH, Lee MC,
Bischoff J and Nguyen M: Human colon cancer cells express multiple
glycoprotein ligands for E-selecin. Int J Oncol. 16:347–353.
2000.PubMed/NCBI
|
|
29
|
Khatib AM, Fallavollita L, Wancewicz EV,
Monia BP and Brodt P: Inhibition of hepatic endothelial E-selectin
expression by C-raf antisense oligonucleotides blocks colorectal
carcinoma liver metastasis. Cancer Res. 62:5393–5398.
2002.PubMed/NCBI
|
|
30
|
Khatib AM, Kontogiannea M, Fallavollita L,
Jamison B, Meterissian S and Brodt P: Rapid induction of cytokine
and E-selectin expression in the liver in response to metastatic
tumor cells. Cancer Res. 59:1356–1361. 1999.PubMed/NCBI
|
|
31
|
Hanley WD, Burdick MM, Konstantopoulos K
and Sackstein R: CD44 on LS174T colon carcinoma cells possesses
E-selectin ligand activity. Cancer Res. 65:5812–5817. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Burdick MM, Chu JT, Godar S and Sackstein
R: HCELL is the major E- and L-selectin ligand expressed on LS174T
colon carcinoma cells. J Biol Chem. 281:13899–13905. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brodt P, Fallavollita L, Bresalier RS,
Meterissian S, Norton CR and Wolitzky BA: Liver endothelial
E-selectin mediates carcinoma cell adhesion and promotes liver
metastasis. Int J Cancer. 71:612–619. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Köhler S, Ullrich S, Richter U and
Schumacher U: E-/P-selectins and colon carcinoma metastasis: First
in vivo evidence for their crucial role in a clinically relevant
model of spontaneous metastasis formation in the lung. Br J Cancer.
102:602–609. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zen K, Liu DQ, Guo YL, Wang C, Shan J,
Fang M, Zhang CY and Liu Y: CD44v4 is a major E-selectin ligand
that mediates breast cancer cell transendothelial migration. PLoS
One. 3:e18262008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shirure VS, Henson KA, Schnaar RL,
Nimrichter L and Burdick MM: Gangliosiedes expressed on breast
cancer cells are E-selectin ligands. Biochem Biophys Res Commun.
406:423–429. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shirure VS, Reynolds NM and Burdick MM:
Mac-2 binding protein is a novel E-selectin ligand expressed by
breast cancer cell. PLoS One. 7:e445292012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dimitroff CJ, Lechpammer M, Long-Woodward
D and Kutok JL: Rolling of human bone-metastatic prostate tumor
cells on human bone marrow endothelium under shear flow is mediated
by E-selectin. Cancer Res. 64:5261–5269. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yoshimoto K, Tajima H, Ohta T, Okamoto K,
Sakai S, Kinoshita J, Furukawa H, Makino I, Hayashi H, Nakamura K,
et al: Increased E-selectin in hepatic ischemia-reperfusion injury
mediates liver metastasis of pancreatic cancer. Oncol Rep.
28:791–796. 2012.PubMed/NCBI
|
|
40
|
Kobayashi K, Matsumoto S, Morishima T,
Kawabe T and Okamoto T: Cimetidine inhibits cancer cell adhesion to
endothelial cells and prevents metastasis by blocking E-selectin
expression. Cancer Res. 60:3978–3984. 2000.PubMed/NCBI
|
|
41
|
Raes G, Ghassabeh GH, Brys L, Mpofu N,
Verschueren H, Vanhecke D and De Baetselier P: The metastatic
T-cell hybridoma antigen/P-selectin glycoprotein ligand 1 is
required for hematogenous metastasis of lymphomas. Int J Cancer.
121:2646–2652. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Aigner S, Sthoeger ZM, Fogel M, Weber E,
Zarn J, Ruppert M, Zeller Y, Vestweber D, Stahel R, Sammar M and
Altevogt P: CD24, a mucin-type glycoprotein, is a ligand for
P-selectin on human tumor cells. Blood. 89:3385–3395.
1997.PubMed/NCBI
|
|
43
|
Alves CS, Burdick MM, Thomas SN, Pawar P
and Konstantopoulos K: The dual role of CD44 as a functional P
selectin ligand and fibrin receptor in colon carcinoma cell
adhesion. Am J Physiol Cell Physiol. 294:C907–C916. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Garcia J, Callewaert N and Borsig L:
P-selectin mediates metastatic progression through binding to
sulfatides on tumor cells. Glycobiology. 17:185–196. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Monzavi-Karbassi B, Stanley JS, Hennings
L, Jousheghany F, Artaud C, Shaaf S and Kieber-Emmons T:
Chondroitin sulfate glycosaminoglycans as major P-selectin ligands
on metastatic breast cancer cell lines. Int J Cancer.
120:1179–1191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Stone JP and Wagner DD: P-selectin
mediates adhesion of platelets to neuroblastoma and small cell lung
cancer. J Clin Invest. 92:804–813. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ludwig RJ, Boehme B, Podda M, Henschler R,
Jager E, Tandi C, Boehncke WH, Zollner TM, Kaufmann R and Gille J:
Endothelial P-selectin as a target of heparin action in
experimental melanoma lung metastasis. Cancer Res. 64:2743–2750.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kim YJ, Borsig L, Varki NM and Varki A:
P-selectin deficiency attenuates tumor growth and metastasis. Proc
Natl Acad Sci USA. 95:9325–9330. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen JL, Chen WX, Zhu JS, Chen NW, Zhou T,
Yao M, Zhang DQ and Wu YL: Effect of P-selectin monoclonal antibody
on metastasis of gastric cancer and immune function. World J
Gastroenterol. 9:1607–1610. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wei M, Tai G, Gao Y, Li N, Huang B, Zhou
Y, Hao S and Zeng X: Modified heparin inhibits P-selectin-mediated
cell adhesion of human colon carcinoma cells to immobilized
platelets under dynamic flow conditions. J Biol Chem.
279:29202–29210. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Gao Y, Wei M, Zheng S, Ba X, Hao S and
Zeng X: Chemically modified heparin inhibits the in vitro adhesion
of nonsmall cell lung cancer cells to P-selectin. J Cancer Res Clin
Oncol. 132:257–264. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Borsig L, Vlodavsky I, Ishai-Michaeli R,
Torri G and Vismara E: Sulfated hexasaccharides attenuate
metastasis by inhibition of P-selectin and heparanase. Neoplasia.
13:445–452. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sperandio M, Smith ML, Forlow SB, Olson
TS, Xia L, McEver RP and Ley K: P-selectin glycoprotein ligand-1
mediates L-selectin dependent leukocyte rolling in venules. J Exp
Med. 197:1355–1363. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Läubli H, Stevenson JL, Varki A, Varki NM
and Borsig L: L-selectin facilitation of metastasis involves
temporal induction of Fut7-dependent ligands at sites of tumor cell
arrest. Cancer Res. 66:1536–1542. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Borsig L, Wong R, Hynes RO, Varki NM and
Varki A: Synergistic effects of L- and P-selectin in facilitating
tumor metastasis can involve non-mucin ligands and implicate
leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA.
99:2193–2198. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Dallas MR, Chen SH, Streppel MM, Sharma S,
Maitra A and Konstantopoulos K: Sialofucosylated podocalyxin is a
functional E- and L-selectin ligand expressed by metastatic
pancreatic cancer cells. Am J Physiol Cell Physiol. 303:C616–C624.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hanley WD, Napier SL, Burdick MM, Schnaar
RL, Sackstein R and Konstantopoulos K: Variant isoforms of CD44 are
P- and L-selectin ligands on colon carcinoma cells. FASEB J.
20:337–339. 2006.PubMed/NCBI
|
|
58
|
Thomas SN, Zhu F, Schnaar RL, Alves CS and
Konstantopoulos K: Carcinoembryonic antigen and CD44 variant
isoforms cooperate to mediate colon carcinoma cell adhesion to E-
and L-selectin in shear flow. J Biol Chem. 283:15647–15655. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Rivera-Calzada A, Robertson D, MacFadyen
JR, Boskovic J, Isacke CM and Llorca O: Three-dimensional interplay
among the ligand-binding domains of the
urokinase-plasminogen-activator-receptor-associated protein,
Endo180. EMBO Rep. 4:807–812. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Jürgensen HJ, Madsen DH, Ingvarsen S,
Melander MC, Gårdsvoll H, Patthy L, Engelholm LH and Behrendt N: A
novel functional role of collagen glycosylation: Interaction with
the endocytic receptor uPARAP/Endo180. J Biol Chem.
286:32736–32748. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Irjala H, Alanen K, Grénman R, Heikkilä P,
Joensuu H and Jalkanen S: Mannose receptor (MR) and common
lymphatic endothelial and vascular endothelial receptor (CLEVER)-1
direct the binding of cancer cells to the lymph vessel endothelium.
Cancer Res. 63:4671–4676. 2003.PubMed/NCBI
|
|
62
|
Marttila-Ichihara F, Turja R, Miiluniemi
M, Karikoski M, Maksimow M, Niemelä J, Martinez-Pomares L, Salmi M
and Jalkanen S: Macrophage mannose receptor on lymphatics controls
cell trafficking. Blood. 112:64–72. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Salmi M, Karikoski M, Elima K, Rantakari P
and Jalkanen S: CD44 binds to macrophage mannose receptor on
lymphatic endothelium and supports lymphocyte migration via
afferent lymphatics. Circ Res. 112:1577–1582. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Götte M and Yip GW: Heparanase,
hyaluronan, and CD44 in cancers: A breast carcinoma perspective.
Cancer Res. 66:10233–10237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wielenga VJ, van der Neut R, Offerhaus GJ
and Pals ST: CD44 glycoproteins in colorectal cancer: Expression,
function, and prognostic value. Adv Cancer Res. 77:169–187. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Leung EL, Fiscus RR, Tung JW, Tin VP,
Cheng LC, Sihoe AD, Fink LM, Ma Y and Wong MP: Non-small cell lung
cancer cells expressing CD44 are enriched for stem cell-like
properties. PLoS One. 5:e140622010. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Jürgensen HJ, Madsen DH, Ingvarsen S,
Melander MC, Gårdsvoll H, Patthy L, Engelholm LH and Behrendt N: A
novel functional role of collagen glycosylation: Interraction with
the endocytic collagen receptor uPARAP/ENDO180. J Biol Chem.
286:32736–32748. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kogianni G, Walker MM, Waxman J and Sturge
J: Endo180 expression with cofunctional partners MT1-MMP and
uPAR-uPA is correlated with prostate cancer progression. Eur J
Cancer. 45:685–693. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Sulek J, Wagenaar-Miller RA, Shireman J,
Molinolo A, Madsen DH, Engelholm LH, Behrendt N and Bugge TH:
Increased expression of the collagen internalization receptor
uPARAP/Endo180 in the stroma of head and neck cancer. J Histochem
Cytochem. 55:347–353. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Wienke D, Davies GC, Johnson DA, Sturge J,
Lambros MB, Savage K, Elsheikh SE, Green AR, Ellis IO, Robertson D,
et al: The collagen receptor Endo180 (CD280) is expressed on
basal-like breast tumor cells and promotes tumor growth in vivo.
Cancer Res. 67:10230–10240. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Huijbers IJ, Iravani M, Popov S, Robertson
D, Al-Sarraj S, Jones C and Isacke CM: A role for fibrillar
collagen deposition and the collagen internalization receptor
endo180 in glioma invasion. PLoS One. 5:e98082010. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Engelholm LH, Ingvarsen S, Jürgensen HJ,
Hillig T, Madsen DH, Nielsen BS and Behrendt N: The collagen
receptor uPARAP/Endo180. Front Biosci (Landmark Ed). 14:2103–2114.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Curino AC, Engelholm LH, Yamada SS,
Holmbeck K, Lund LR, Molinolo AA, Behrendt N, Nielsen BS and Bugge
TH: Intracelluar collagen degradation mediated by uPARAP/Endo180 is
a major pathway of extracellular matrix turnover during malignancy.
J Cell Biol. 169:977–985. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Palmieri C, Caley MP, Purshouse K, Fonseca
AV, Rodriguez-Teja M, Kogianni G, Woodley L, Odendaal J, Elliott K,
Waxman J and Sturge J: Endo180 modulation by bisphosphonates and
diagnostic accuracy in metastatic breast cancer. Br J Cancer.
108:163–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Takahashi S, Yamada-Okabe H, Hamada K,
Ohta S, Kawase T, Yoshida K and Toda M: Downregulation of uPARAP
mediates cytoskeletal rearrangements and decreases invasion and
migration properties in glioma cells. J Neurooncol. 103:267–276.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
George JN: Platelets. Lancet.
355:1531–1539. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Takagi S, Sato S, Oh-hara T, Takami M,
Koike S, Mishima Y, Hatake K and Fujita N: Platelets promote tumor
growth and metastasis via direct interaction between
Aggrus/podoplanin and CLEC-2. PLoS One. 8:e736092013. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Lowe KL, Finney BA, Deppermann C,
Hägerling R, Gazit SL, Frampton J, Buckley C, Camerer E, Nieswandt
B, Kiefer F and Watson SP: Podoplanin and CLEC-2 drive
cerebrovascular patterning and integrity during development. Blood.
125:3769–3777. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Lowe KL, Navarro-Nunez L and Watson SP:
Platelet CLEC-2 and podoplanin in cancer metastasis. Thromb Res.
129:(Suppl 1). S30–S37. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Martín-Villar E, Scholl FG, Gamallo C,
Yurrita MM, Muñoz-Guerra M, Cruces J and Quintanilla M:
Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a
small membrane mucin induced in oral squamous cell carcinomas. Int
J Cancer. 113:899–910. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Rodrigo JP, Garcia-Carracedo D, González
MV, Mancebo G, Fresno MF and García-Pedrero J: Podoplanin
expression in the development and progression of laryngeal squamous
cell carcinomas. Mol Cancer. 9:482010. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Kato Y, Kaneko M, Sata M, Fujita N, Tsuruo
T and Osawa M: Enhanced expression of Aggrus (T1alpha/podoplanin),
a platelet-aggregation-inducing factor in lung squamous cell
carcinoma. Tumour Biol. 26:195–200. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Kimura N and Kimura I: Podoplanin as a
marker for mesothelioma. Pathol Int. 55:83–86. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Kato Y, Fujita N, Kunita A, Sato S, Kaneko
M, Osawa M and Tsuruo T: Molecular identification of Aggrus/T1alpha
as a platelet aggregation-inducing factor expressed in colorectal
tumors. J Biol Chem. 278:51599–51605. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Mishima K, Kato Y, Kaneko MK, Nishikawa R,
Hirose T and Matsutani M: Increased expression of podoplanin in
malignant astrocytic tumors as a novel molecular marker of
malignant progression. Acta Neuropathol. 111:483–488. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Liang M, Zhang P and Fu J: Up-regulation
of LOX-1 expression by TNF-alpha promotes trans-endothelial
migration of MDA-MB-231 breast cancer cells. Cancer Letters.
258:31–37. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Zhang F, Ren S and Zuo Y: DC-SIGN,
DC-SIGNR and LSECtin: C-Type Lectins for Infection. Int Rev
Immunol. 33:54–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Nonaka M, Ma BY, Murai R, Nakamura N, Baba
M, Kawasaki N, Hodohara K, Asano S and Kawasaki T:
Glycosylation-dependent interactions of C-type lectin DC-SIGN with
colorectal tumor-associated Lewis glycans impair the function and
differentiation of monocyte-derived dendritic cells. J Immunol.
180:3347–3356. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Xu F, Liu J, Liu D, Liu B, Wang M, Hu Z,
Du X, Tang L and He F: LSECtin expressed on melanoma cells promotes
tumor progression by inhibiting antitumor T-cell responses. Cancer
Res. 74:3418–3428. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zhang Z, Chen K, Yan L, Yang Z, Zhu Z,
Chen C, Zeng J, Wei W, Qi X, Ren S and Zuo Y: Low expression of
dendritic cell-specific intercellular adhesion molecule-grabbing
nonintegrin-related protein in non-Hodgkin lymphoma and significant
correlations with lactic acid dehydrogenase and β2-microglobulin.
Biochem Cell Biol. 91:214–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Keler T, Ramakrishna V and Fanger MW:
Mannose receptor-targeted vaccines. Expert Opin Biol Ther.
4:1953–1962. 2004. View Article : Google Scholar : PubMed/NCBI
|
